Right Atrial Function in PAH
in the IMPRES cohort from patients referred to the echocardiographic laboratory at the Brigham and Women's Hospital to serve as a healthy comparator group. Patients were referred for echocardiography for any of the following indications: murmur, evaluation of LV function, syncope, or atypical chest pain. Subjects were included if they were free of cardiovascular disease or cardiovascular risk factors (hypertension, diabetes mellitus, hyperlipidemia, smoking, renal dysfunction), were not taking any cardiovascular medications, were free of significant systemic diseases by retrospective review of the electronic medical record, and had adequate image quality with an LV ejection fraction >55%, no regional wall motion abnormalities, and no other cardiac structural or functional abnormality based on current recommendations of the American Society of Echocardiography. 15 The Brigham and Women's Hospital Institutional Review Board approved the study protocol.
Standard Echocardiographic Methods
Details of the IMPRES echocardiography substudy, including reproducibility metrics, have been previously published. 13 Briefly, all IMPRES patients underwent an echocardiography following the same echocardiographic protocol. RV functional measures, including tricuspid annular peak systolic velocity, tricuspid annular plane systolic excursion, RV Tei index, and RV fractional area change (RVFAC) were measured in accordance with the American Society of Echocardiography guidelines. 16 Right heart size was quantified as RV diastolic area and RA area at end systole. Tricuspid regurgitation (TR) severity was assessed by measuring the jet area of the TR and graduated as none, mild (TR area <5 cm 2 ), moderate (TR area between 5 and 10 cm 2 ), and severe (TR area >10 cm 2 ). 17 LV volumes 
Strain Analysis
Digitally acquired baseline echocardiographic images in Digital Imaging and Communications in Medicine format with acceptable image quality were uploaded to the Tomtec system (Munich, Germany). Strain analysis was performed in all studies with adequate image quality. Inadequate quality was defined as poor visualization or poor tracking of ≥2 atrial segments. RV performance by speckle tracking was used to calculated RV free wall longitudinal strain (FWLS) as previously described. 14 For RA deformation, the RA endocardial border was traced at ventricular end systole in the apical 4-chamber view. The software then tracks speckles along the endocardial border throughout the cardiac cycle and derives the LS and longitudinal strain rate (LSR). Three different LSR measures are calculated: (1) peak LSR which is coincident with RV systole and reflects the maximal RA distension; (2) early LSR which is coincident with RV E wave and reflects the passive RA emptying; and (3) late LSR which is coincident with RV A wave and reflects active RA emptying. The following phasic RA volumes were also determined: (1) RA maximal volume; (2) RA preemptying volume which is measured at the beginning of the p wave of the ECG; and (3) RA minimal volume. RA emptying fraction was defined as (RA maximal volume-RA minimal volume)/RA maximal volume. RA passive emptying fraction was defined as (RA maximal volume-RA pre-emptying volume)/RA maximal volume. RA active emptying fraction was defined as (RA pre-emptying volume-RA minimal volume)/RA pre-emptying volume. To assess the contribution of each RA emptying phase to the total RV filling, we also calculated the ratio of RA passive and active emptying fraction to the total RA emptying fraction. As previously published, 9 3 different phases of RA function can be defined ( Figure 1 ): (1) reservoir function which reflects the ability of the RA to distend and is assessed by the RA LS, RA peak LSR, and RA emptying fraction; (2) conduit function which reflects the passive emptying phase of the RA as a result of tricuspid valve opening and RV relaxation and is assessed by RA early LSR and RA passive emptying fraction; and (3) RA active contraction which is assessed by RA late LSR and RA active emptying fraction.
All measurements were performed by a single investigator blinded to clinical status. Intraobserver variability for RA LS was assessed in a sample of 30 randomly selected patients (20 subjects from the IMPRES group and 10 subjects from the control group). The coefficients of variation for RA measures were as follows: RA LS 11%, peak LSR 17%, early LSR 20%, and late LSR 25%.
Right Heart Catheterization
All IMPRES patients underwent right heart catheterization on the same day as baseline echocardiography as previously described. 13, 14 Invasive hemodynamic measurements were not available in the control group.
Statistical Analysis
Continuous variables are presented as mean and standard deviation or median and first and third quartiles if not normally distributed. Categorical variables are presented as percentages. Comparisons between PAH patients and controls were performed using a Student's t test for continuous normally distributed variables, Mann-Whitney test for continuous non-normally distributed variables, and a Fisher exact test for categorical variables. Additional comparison of between-group differences was performed using multivariable linear regression adjusting for RA maximal area and maximum inferior vena cava width, an established echocardiographic surrogate of RA pressure. Finally, between-group comparisons were performed after additional multivariable adjustment for the following demographic, clinical, and echocardiographic variables that may influence RA size or function: age, sex, body mass index, heart rate, systolic blood pressure, maximal RA area, maximal inferior vena cava width, right ventricular function as measured by RVFAC, and TR severity. In a subgroup analysis, we further divided the PAH group into normal RA size (RA area <18 cm 2 ) 15 and enlarged RA (RA area ≥18 cm 2 ). In addition, given the differences in race/ethnicity between the control group and PAH subjects, we performed a sensitivity analysis restricted to white control and PAH subjects. Among patients with PAH, we determined the association between RA LS and invasive hemodynamic measurements, N-terminal pro brain natriuretic peptide (NT-proBNP), and echocardiographic measures of RV structure and function using Pearson's correlation and after adjustment for RA maximal volume using multivariable linear regression. All analyses were performed using STATA 12.0 (StataCorp LP. 2009, TX).
Results
Of the 74 patients included in the echocardiographic substudy, RA function could be assessed in 65. Six studies could not be analyzed because of technical issues, 2 patients could not be analyzed because of inadequate quality, and 1 patient was excluded because of atrial fibrillation ( Figure 2 ). Patients included in the strain study did not significantly differ from the overall IMPRES population in demographics, clinical characteristics, or invasive hemodynamics at baseline.
PAH patients from the IMPRES study were 50.0±13.6 years old, white (100%), and the majority were women (83%; Table 1 ). No significant differences in age, sex, or body mass index were noted between the PAH and control groups. However, patients with PAH showed significantly lower blood pressure, higher heart rate, and severely impaired RV function based on echocardiographic measurements. Patients with PAH also had significantly larger RA area compared with controls (15.0±4.7 cm 2 versus , P<0.001) and larger inferior vena cava diameter. Among PAH patients, those with enlarged RA compared with those with normal RA size were older, had lower RV stroke volume, higher NT-proBNP, worse RV function (reflected in lower RVFAC and RV FWLS), and more severe TR (Table 2) .
Right Atrial Reservoir Function
Compared with controls, patients with PAH had significantly impaired RA reservoir function as reflected by impaired RA LS (56.9±12.7 versus 27.1±11.6, P<0.0001), RA peak LSR (2.1±0.6 versus 1.4±0.6, P<0.0001), and RA emptying fraction (66±10 versus 51±15, P<0.0001; Table 3 ). All differences were independent of age, sex, body mass index, systolic blood pressure, and heart rate, but only differences in RA LS remained significant after additionally adjusting for RA area, inferior vena cava width, RVFAC, and TR severity. The between-group difference in RA strain remained significant when adjusting for Tei index instead of RVFAC as a measure of RV function in the multivariable BMI indicates body mass index; DBP, diastolic blood pressure; FWLS, free wall longitudinal strain; HR, heart rate; IVC, inferior vena cava; LA, left atrium; LVEF, left ventricular ejection fraction; LVEDV, left ventricle end diastolic volume; MPAP, mean pulmonary arterial pressure; NT-proBNP, N-terminal pro brain natriuretic peptide; PAH, pulmonary arterial hypertension; PCWP, pulmonary capillary wedge pressure; PVR, pulmonary vascular resistance; RA, right atrial; RAP, right atrial pressure; RV, right ventricular; RVEDA, right ventricular end diastolic area; RVFAC, RV fractional area change; SBP, systolic blood pressure; SVI, stroke volume index; TAPSE, tricuspid annular plane systolic excursion; TA S′, peak systolic velocity; TR, Tricuspid regurgitation; and 6MWDT, 6-minutes walk distance test. Right Atrial Function in PAH model (P=0.002), although the between-group difference did not achieve statistical significance when adjusting for RV FWLS instead of RVFAC as measure of RV function (P=0.21). In a subgroup analysis, RA LS and RA peak LSR remained significantly impaired in the PAH patients with normal RA size (n=11) compared with controls ( Figure 3 ; Table I in the Data Supplement), whereas RA emptying fraction was not significantly different. Concordant results were seen for the RA reservoir function in a sensitivity analysis excluding nonwhite subjects from the control group (Table II in 
Right Atrial Conduit and Active Function
Measures of passive conduit function, RA early LSR, and RA passive emptying fraction, as well as the RA passive emptying fraction/total RA emptying fraction ratio-which reflects the contribution of RA passive emptying to total RA emptying-were BMI indicates body mass index; DBP, diastolic blood pressure; FWLS, free wall longitudinal strain; HR, heart rate; IVC, inferior vena cava; LA, left atrium; LVEF, left ventricular ejection fraction; LVEDV, left ventricle end diastolic volume; MPAP, mean pulmonary arterial pressure; NT-proBNP, N-terminal pro brain natriuretic peptide; PAH, pulmonary arterial hypertension; PCWP, pulmonary capillary wedge pressure; PVR, pulmonary vascular resistance; RA, right atrial; RAP, right atrial pressure; RV, right ventricular; RVEDA, right ventricular end diastolic area; RVFAC, RV fractional area change; SBP, systolic blood pressure; SVI, stroke volume index; TAPSE, tricuspid annular plane systolic excursion; TA S′, peak systolic velocity; TR, Tricuspid regurgitation; and 6MWDT, 6-minutes walk distance test.
*Based on Mann-Whitney test. †Based on t test performed with log-transformed values.
significantly impaired in PAH patients compared with controls (Table 3 ). In contrast, measures of active contraction, RA late LSR and RA active emptying fraction, did not significantly differ in PAH patients compared with controls ( Table 3 ). The RA active emptying fraction/RA total emptying fraction ratio was significantly higher among PAH patients (Table 3) , reflecting a greater relative contribution of the active phase to the RA total emptying fraction in PAH. Sensitivity analysis excluding nonwhite subjects from the control group demonstrated concordant results with the primary analysis with respect to RA active and conduit function (Table II in plane systolic excursion, and with indirect measures of RV overload, including RV end diastolic area, the RV:LV area ratio, and the diastolic LV eccentricity index. Worse RA LS also correlated with higher NT-proBNP. Adjustment of TR severity did not substantively alter the association between RA LS and RA size or pressure, echocardiographic measurements of RV function, or NT-proBNP. Despite associations with RV dysfunction and overload, RA LS was not associated with invasively measured mean pulmonary arterial pressure or pulmonary vascular resistance.
Discussion
In patients with severe PAH, RA function is impaired compared with that in healthy controls, as reflected by lower values of RA LS independent of RA size. The impairment in RA LS is mainly because of a significant reduction in RA passive reservoir and conduit functions, whereas RA active function is preserved and has a greater relative contribution to RV diastolic filling. Independent of its associations with RA size and pressure, impaired RA LS is associated with RV dysfunction and overload but not pulmonary hemodynamics. RA LS was reduced in PAH patients compared with controls, even in the 11 PAH patients with preserved RA size, suggesting that RA function may play a role in the progression of PAH. Both reservoir function, occurring coincident with ventricular contraction, and conduit function, corresponding to rapid passive ventricular filling because of tricuspid valve opening, were impaired in PAH compared with controls. In contrast, RA contraction was preserved in PAH compared with controls and responsible for a greater proportion of RV diastolic filling in PAH, likely as a compensatory mechanism for the reduced passive conduit emptying. Similar results were previously described by Willens et al 8 in a group of PAH patients. That group also described similar adaptations associated with aging. Interestingly, a similar pattern of alteration in atrial phasic function has also been described for LA function in the presence of severe aortic stenosis, where LV filling becomes highly dependent of LA contraction. These findings suggest that the loss of this compensatory mechanism, either because of atrial fibrillation or possibly RA fatigue, may play an important role in the prognosis of patients with PAH.
RA LS showed moderate correlations with RA size measured by echocardiography and with RA pressure measured invasively, both of which have demonstrated prognostic value in PAH. 5, 6 These associations suggest that RA LS may also provide prognostic information in these patients. Interestingly, parallel associations have been observed with LA strain in patients with LV failure. Cameli et al 19 showed that LA LS is associated with invasive pulmonary capillary wedge pressure in patients with left heart failure and proposed LA LS as an estimator of LA filling pressures.
RA LS did not show associations with invasive pulmonary hemodynamics. In contrast, RA LS was significantly correlated with RV longitudinal function (RV FWLS and tricuspid annular plane systolic excursion) and with measures of RV overload, including NT-proBNP. These findings suggest that impaired RA function may manifest in PAH primarily when the RV becomes overloaded and begins to fail. Indeed, RV failure is one of the most important risk factors for death in PAH. However, RV structure and function have been difficult to reliably assess in PAH by echocardiography likely because of distortion of the already complex geometry of the RV in these patients. 1 The RA is a simpler geometric structure, and it is therefore possible that RA LS may provide a simpler, easier, more reliable, and faster noninvasive measure of RV decompensation and-potentially-prognosis than other standard echocardiographic RV measurements. In our study of patients with advanced PAH, assessment of RA deformation was faster and feasible in a greater proportion of patients than were quantitative measures of RV function (97% versus 88%, respectively), particularly among patients with a massively dilated RV that was unable to be fully included in the echo acquisition window. However, it is still too early to claim incremental value of RA deformation assessment beyond conventional assessment of RA size.
Several limitations of this post hoc analysis should be noted. We have analyzed RA function measures using an LV-specific software because no vendor-independent commercial software was available for dedicated RA analysis by deformation imaging at the time of this study. Importantly, although validation of speckle-tracking echocardiographybased measures of LS with sonomicrometry or MRI have been performed for the LV, the use of such software initially developed for the LV to assess the RV is well established, 20 and previous studies have shown the validity of such software in the analysis of LA strain 11, 19 and RA strain. 12 RV diastolic pressures were not assessed, limiting our ability to study the potential association of RV diastolic pressure with RA function and its potential contribution to the observed betweengroup differences in RA function. Intrareader reproducibility of RA LS was acceptable, whereas intrareader variability of RA LSR measurements (particularly late LSR) was higher and should therefore be interpreted with caution. Finally, IMPRES was not powered for outcomes, limiting our ability to study the predictive value of measurements of RA deformation.
Conclusions
RA reservoir and passive conduit functions are impaired in PAH, independent of RA size and pressure. Worse RA LS in PAH is associated with greater RV dysfunction and overload, but not with pulmonary hemodynamics. Additional studies are necessary to determine whether RA LS has prognostic value in PAH.
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